Australian Approved Name (AAN): d-ribose-l-cysteine
Common name/s and synonyms: 2-(1,2,3,4-Tetrahydroxybutyl)thiazolidine-4-carboxylic acid
Mandatory components: Cysteine
Warnings and restrictions: Only for use in oral medicines. The medicine must provide no more than 450mg of cysteine per maximum recommended daily dose.
Allowable purpose of the ingredient: Active
TGA reference: CHEMID plus (National Library of Medicine)